US Stock MarketDetailed Quotes
AZN AstraZeneca
- 77.470
- -0.460-0.59%
Close Oct 4 16:00 ET
- 77.470
- 0.0000.00%
Post 20:02 ET
240.20BMarket Cap37.61P/E (TTM)
77.550High76.900Low5.19MVolume77.080Open77.930Pre Close400.25MTurnover0.17%Turnover Ratio40.67P/E (Static)3.10BShares87.67552wk High6.08P/B239.35BFloat Cap59.19052wk Low1.45Dividend TTM3.09BShs Float87.675Historical High1.87%Div YieldTTM0.83%Amplitude5.373Historical Low77.167Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
AstraZeneca Stock Forum
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve. Esperion...
FDA Approves Osimertinib For Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer After Chemoradiation Therapy; Recommended Dose Is 80mg Daily Until Disease Progression Or Unacceptable Toxicity
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks you wish you had bought. Esperion is HUGELY Undervalued, company sells the ONLY statin alternative drugs with New FDA approved Primary Prevention Labels in 2024. Insurance companies are j...
The current market-cap is below $350 million, with $200 million cash on hand, and $900 million in future milestones, with $140...
The move surpassed Wall Street's expectations. Analysts had generally anticipated a 25 basis point cut, while the futures market had priced in a 61% probability of a 50 basis point cut and a 39% probability of a 25 basis point reduction.
Market Response to First Rate Cut
St...
Gapping up
$Oracle (ORCL.US)$ Shares of Oracle surged over 6.2% as the company increased its revenue forecast for fiscal 2026 and provided strong guidance for the fiscal year 2029.
$Restoration Hardware (RH.US)$ Shares of the home furnishings retailer jumped 18.9% following a robust second quarter. RH reported adjusted earnings per share of $1.69 on revenue of $830 million, surpassing analysts' expectations of $1.56 p...
No comment yet